These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18842175)

  • 21. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.
    Chen YJ; Shen JL; Wu CY; Chang YT; Chen CM; Lee FY
    J Am Acad Dermatol; 2009 Feb; 60(2):225-30. PubMed ID: 19028408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease.
    Rossetto V; Spiezia L; Franz F; Salmaso L; Pozza LV; Gavasso S; Simioni P
    Am J Hematol; 2009 Sep; 84(9):594-6. PubMed ID: 19565645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of onychomycosis among psoriatic patients in Israel.
    Leibovici V; Hershko K; Ingber A; Westerman M; Leviatan-Strauss N; Hochberg M
    Acta Derm Venereol; 2008; 88(1):31-3. PubMed ID: 18176747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anetoderma secondary to antiphospholipid antibodies.
    Eungdamrong J; Fischer M; Patel R; Meehan S; Sanchez M
    Dermatol Online J; 2012 Dec; 18(12):26. PubMed ID: 23286816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis.
    Balci DD; Duran N; Ozer B; Gunesacar R; Onlen Y; Yenin JZ
    Eur J Dermatol; 2009; 19(3):238-42. PubMed ID: 19286488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of antiphospholipid antibodies in children and adolescents.
    Kratz C; Mauz-Körholz C; Kruck H; Körholz D; Göbel U
    Pediatr Hematol Oncol; 1998; 15(4):325-32. PubMed ID: 9658433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
    Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
    J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombophilia and unexplained pregnancy loss in Indian patients.
    Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
    Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma neuropeptides and perception of pruritus in psoriasis.
    Reich A; Orda A; Wiśnicka B; Szepietowski JC
    Acta Derm Venereol; 2007; 87(4):299-304. PubMed ID: 17598031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
    Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
    Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.